Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin Journal Article


Authors: May, C.; Rivella, S.; Callegari, J.; Heller, G.; Gaensler, K. M. L.; Luzzatto, L.; Sadelain, M.
Article Title: Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
Abstract: The stable introduction of a functional β-globin gene in haematopoietic stem cells could be a powerful approach to treat β-thalassaemia and sickle- cell disease. Genetic approaches aiming to increase normal β-globin expression in the progeny of autologous haematopoietic stem cells might circumvent the limitations and risks of allogeneic cell transplants. However, low-level expression, position effects and transcriptional silencing hampered the effectiveness of viral transduction of the human β-globin gene when it was linked to minimal regulatory sequences. Here we show that the use of recombinant lentiviruses enables efficient transfer and faithful integration of the human β-globin gene together with large segments of its locus control region. In long-term recipients of unselected transduced bone marrow cells, tetramers of two murine α-globin and two human β(A)-globin molecules account for up to 13% of total haemoglobin in mature red cells of normal mice. In β-thalassaemic heterozygous mice higher percentages are obtained (17% to 24%), which are sufficient to ameliorate anaemia and red cell morphology. Such levels should be of therapeutic benefit in patients with severe defects in haemoglobin production.
Keywords: protein expression; nonhuman; animal cell; mouse; animals; mice; cell line; animalia; genetic vectors; transduction, genetic; recombinant proteins; gene therapy; lentivirus; beta thalassemia; beta-thalassemia; murinae; bone marrow transplantation; hemoglobins; hiv-1; lentivirinae; globins; gene transfer techniques; sickle cell anemia; hemoglobin synthesis; humans; male; female; priority journal; article; beta globulin
Journal Title: Nature
Volume: 406
Issue: 6791
ISSN: 0028-0836
Publisher: Nature Publishing Group  
Date Published: 2000-07-06
Start Page: 82
End Page: 86
Language: English
DOI: 10.1038/35017565
PUBMED: 10894546
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 18 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Chad May
    21 May
  2. Glenn Heller
    399 Heller
  3. Stefano Rivella
    16 Rivella
  4. Michel W J Sadelain
    583 Sadelain
  5. Lucio Luzzatto
    105 Luzzatto